<qa>  What is the name of the study that was conducted in patients with unresectable and metaA multicenter uncontrolled study of sorafenib in patients with unresectable andor metastatic renal cell carcinoma RCC to assess the pharmacokinetic profile, safety and tolerability, and efficacy. 